Immunosuppressive therapy for progressive ocular cicatricial pemphigoid

Area of Science:

• Ophthalmology
• Immunology
• Rheumatology

Background:

• Progressive cicatricial pemphigoid is an autoimmune condition causing ocular inflammation and scarring.
• Current treatment options for ocular cicatricial pemphigoid are limited.

Observation:

• A longitudinal cohort study compared systemic immunosuppression with conventional therapy in 26 patients.
• 18 patients received immunosuppressive drugs, while 8 received conventional treatment.

Findings:

• 15 of 18 immunosuppressed patients achieved cessation of ocular inflammation and scarring, preserving or improving vision.
• Control patients and those withdrawing from immunosuppression experienced progressive visual loss.
• Common complications of immunosuppression included alopecia, anemia, and gastrointestinal distress.

Implications:

• Systemic immunosuppression demonstrates efficacy in managing progressive ocular cicatricial pemphigoid.
• Abnormal immunoregulatory mechanisms are implicated in the disease's progression.
• Immunosuppressive therapy may represent an appropriate treatment strategy for this condition.